© 1998 by European Society of Cardiology
Copyright © 1998, European Society of Cardiology
The discovery of endothelins
National Cardiovascular Center, Fujishirodai 5-7-1, Suita, Osaka 565, Japan
Received 18 March 1998; accepted 13 May 1998
| The first 150 words of the full text of this article appear below. |
It is generally accepted that the vascular endothelium is not a simple barrier between the blood stream and vascular bed. It has many functions in the regulation of vascular function that are mediated by various factors released from the endothelium which act on itself or other vascular cells in autocrine and paracrine manners. This concept emerged after the discovery of the endothelium-derived relaxing factor (EDRF) in 1980. The EDRF was later characterized as nitric oxide in 1987. Before the discovery of the EDRF, prostacycline was discovered, which is also a relaxing factor produced by the endothelium. These two relaxing factors are released from endothelial cells in response to a variety of vasoactive substances, and are thought to regulate vascular tone.
In contrast to endothelium-derived relaxing factors, less progress had been made in the field of endothelium-derived constricting factors such as thromboxane, a strong vasoconstrictor which is produced in the endothelium.
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
P. J. Troy and A. B. Waxman Review: Portopulmonary hypertension: challenges in diagnosis and management Therapeutic Advances in Gastroenterology, September 1, 2009; 2(5): 281 - 286. [Abstract] [PDF] |
||||
![]() |
W. M Maharsy, L. N Kadi, N. G Issa, K. M Bitar, A. H Der-Boghossian, R. Abrahamian, and A. B Bikhazi Cross-talk related to insulin and angiotensin II binding on myocardial remodelling in diabetic rat hearts Journal of Renin-Angiotensin-Aldosterone System, June 1, 2007; 8(2): 59 - 65. [Abstract] [PDF] |
||||
![]() |
J. Y. C. Tsang, W. J. E. Lamm, B. Neradilek, N. L. Polissar, and M. P. Hlastala Endothelin receptor blockade does not improve hypoxemia following acute pulmonary thromboembolism J Appl Physiol, February 1, 2007; 102(2): 762 - 771. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. A. Sarafidis and G. L. Bakris Insulin and Endothelin: An Interplay Contributing to Hypertension Development? J. Clin. Endocrinol. Metab., February 1, 2007; 92(2): 379 - 385. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. S. Hassan, T. M. Williams, P. G. Frank, and M. P. Lisanti Caveolin-1-deficient aortic smooth muscle cells show cell autonomous abnormalities in proliferation, migration, and endothelin-based signal transduction Am J Physiol Heart Circ Physiol, June 1, 2006; 290(6): H2393 - H2401. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. S. Hassan, S. Mukherjee, F. Nagajyothi, L. M. Weiss, S. B. Petkova, C. J. de Almeida, H. Huang, M. S. Desruisseaux, B. Bouzahzah, R. G. Pestell, et al. Trypanosoma cruzi Infection Induces Proliferation of Vascular Smooth Muscle Cells Infect. Immun., January 1, 2006; 74(1): 152 - 159. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. N. Channick, O. Sitbon, R. J. Barst, A. Manes, and L. J. Rubin Endothelin receptor antagonists in pulmonary arterial hypertension J. Am. Coll. Cardiol., June 16, 2004; 43(12_Suppl_S): 62S - 67S. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Galie, A. Manes, and A. Branzi The endothelin system in pulmonary arterial hypertension Cardiovasc Res, February 1, 2004; 61(2): 227 - 237. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. H.S. Kim and L. J. Rubin Endothelin in Health and Disease: Endothelin Receptor Antagonists in the Management of Pulmonary Artery Hypertension Journal of Cardiovascular Pharmacology and Therapeutics, March 1, 2002; 7(1): 9 - 19. [Abstract] [PDF] |
||||
![]() |
T. F. Luscher and M. Barton Endothelins and Endothelin Receptor Antagonists : Therapeutic Considerations for a Novel Class of Cardiovascular Drugs Circulation, November 7, 2000; 102(19): 2434 - 2440. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Barnes and A. J Turner Endothelin converting enzyme is located on {alpha}-actin filaments in smooth muscle cells Cardiovasc Res, June 1, 1999; 42(3): 814 - 822. [Abstract] [Full Text] [PDF] |
||||









